A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The role of perfusion computed tomography (pCT) in detecting changes in tumor vascularization as part of a response to antiangiogenic therapy in non-small cell lung cancer (NSCLC) remains unclear.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cancers (Basel)

Title: Cancers

Publisher: MDPI AG

ISSN: 2072-6694

ISSN (Print): 2072-6694

Publication date (Electronic): Nov 06 2021

Volume: 13

Issue: 21

Affiliations

[1 ] Department of Medical Oncology, Hospital Clínic, 08036 Barcelona, Spain.

[2 ] Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, 08036 Barcelona, Spain.

[3 ] Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.

[4 ] Pompeu Fabra University, 08002 Barcelona, Spain.

[5 ] Department of Radiology, Hospital Clínic, 08036 Barcelona, Spain.

[6 ] Thoracic Oncology Unit, Hospital Clínic, 08036 Barcelona, Spain.

Article

Publisher Item ID: cancers13215566

DOI: 10.3390/cancers13215566

PMC ID: 8583202

PubMed ID: 34771728

SO-VID: 1012ebbc-5ffc-44f0-a609-0d63c8277823

History

Keywords: perfusion CT,tumor perfusion,imaging,biomarkers,bevacizumab,antiangiogenic,NSCLC

Data availability:

Keywords: perfusion CT, tumor perfusion, imaging, biomarkers, bevacizumab, antiangiogenic, NSCLC

Comments

Comment on this article

scite_

Cited by 1

Difference of serum tumor markers in different clinical stages of elderly patients with non-small cell lung cancer and evaluation of diagnostic value
Authors: Wen Wen Qin, Ping Wang, CuiMin Ding …

See all cited by